Protocol F1J-MC-HMEO duloxetine versus placebo in the treatment of chronic low back pain

Trial Profile

Protocol F1J-MC-HMEO duloxetine versus placebo in the treatment of chronic low back pain

Completed
Phase of Trial: Phase III

Latest Information Update: 05 Jan 2010

At a glance

  • Drugs Duloxetine (Primary)
  • Indications Back pain
  • Focus Registrational; Therapeutic Use
  • Sponsors Eli Lilly
  • Most Recent Events

    • 01 Sep 2009 Results were published in the European Journal of Neurology.
    • 01 Sep 2009 Primary endpoint 'Pain intensity' has not been met.
    • 25 Aug 2008 Results presented at the 2008 EFNS, according to an Eli Lilly media release. Actual patient number is 404.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top